Loading…

The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling

Abstract Wear particle-induced aseptic prosthetic loosening is one of the most common reasons for total joint arthroplasty (TJA). Extensive bone destruction (osteolysis) by osteoclasts plays an important role in wear particle-induced peri-implant loosening. Thus, strategies for inhibiting osteoclast...

Full description

Saved in:
Bibliographic Details
Published in:Biomaterials 2014-08, Vol.35 (24), p.6299-6310
Main Authors: Zhai, Zanjing, Qu, Xinhua, Li, Haowei, Yang, Ke, Wan, Peng, Tan, Lili, Ouyang, Zhengxiao, Liu, Xuqiang, Tian, Bo, Xiao, Fei, Wang, Wengang, Jiang, Chuan, Tang, Tingting, Fan, Qiming, Qin, An, Dai, Kerong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c435t-26b7ba49b95de06512d5a9af2a1cb14626aefae97383b758be867f8de254e6b43
cites cdi_FETCH-LOGICAL-c435t-26b7ba49b95de06512d5a9af2a1cb14626aefae97383b758be867f8de254e6b43
container_end_page 6310
container_issue 24
container_start_page 6299
container_title Biomaterials
container_volume 35
creator Zhai, Zanjing
Qu, Xinhua
Li, Haowei
Yang, Ke
Wan, Peng
Tan, Lili
Ouyang, Zhengxiao
Liu, Xuqiang
Tian, Bo
Xiao, Fei
Wang, Wengang
Jiang, Chuan
Tang, Tingting
Fan, Qiming
Qin, An
Dai, Kerong
description Abstract Wear particle-induced aseptic prosthetic loosening is one of the most common reasons for total joint arthroplasty (TJA). Extensive bone destruction (osteolysis) by osteoclasts plays an important role in wear particle-induced peri-implant loosening. Thus, strategies for inhibiting osteoclast function may have therapeutic benefit for prosthetic loosening. Here, we mimicked the process of magnesium (Mg) degradation in vivo and obtained Mg leach liquor (MLL) by immersing pure Mg in culture medium. For the first time, we demonstrated that MLL suppresses osteoclast formation, polarization, and osteoclast bone resorption in vitro . An in vivo assay demonstrated that MLL attenuates wear particle-induced osteolysis. Furthermore, we found that MLL significantly inhibits nuclear factor-κB (NF-κB) activation by retarding inhibitor-κB degradation and subsequent NF-κB nuclear translocation. We also found that MLL attenuates the expression of NFATc1 at both the protein and mRNA levels. These results demonstrate that MLL has anti-osteoclast activity in vitro and prevents wear particle-induced osteolysis in vivo . Collectively, our study suggests that metallic magnesium, one of the orthopedic implants with superior properties, has significant potential for the treatment of osteolysis-related diseases caused by excessive osteoclast formation and function.
doi_str_mv 10.1016/j.biomaterials.2014.04.044
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1529842307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0142961214004426</els_id><sourcerecordid>1529842307</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-26b7ba49b95de06512d5a9af2a1cb14626aefae97383b758be867f8de254e6b43</originalsourceid><addsrcrecordid>eNqNUsGO1DAMjRCIHRZ-AUWcuHRI0iRtOSAtCwNIq-XAcI7SxB0ytMmSpEjzAfwUH8E3kdIFIU5IlhLb79mynxF6QsmWEiqfHbe9C5POEJ0e05YRyrdkMX4HbWjbtJXoiLiLNiXBqk5SdoYepHQkxSec3UdnjLdUslZs0Lf9J8AwDGAyDgOeIOtxdAZP-uAhuXnCFg5RW51d8PgmBjubnHD5h5QhmFGnXDlfomDX0HhKLmHtLdY5g59XZql9vat-fH_5K3O9u9gbipM7eD06f3iI7g1lFHh0-56jj7vX-8u31dX7N-8uL64qw2uRKyb7pte86zthgUhBmRW60wPT1PSUSyY1DBq6pm7rvhFtD61shtYCExxkz-tz9HStWwb5MkPKanLJwDhqD2FOigrWtZzVpCnQ5yvUxJBShEHdRDfpeFKUqEUGdVR_y6AWGRRZbOnz-LbP3E9g_1B_770AXq0AKNN-dRBVMg58WaKLRQplg_u_Pi_-KWPKOp3R42c4QTqGOfqFQ1ViiqgPy0Es91DuoNCZrH8CDde33w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1529842307</pqid></control><display><type>article</type><title>The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling</title><source>Elsevier</source><creator>Zhai, Zanjing ; Qu, Xinhua ; Li, Haowei ; Yang, Ke ; Wan, Peng ; Tan, Lili ; Ouyang, Zhengxiao ; Liu, Xuqiang ; Tian, Bo ; Xiao, Fei ; Wang, Wengang ; Jiang, Chuan ; Tang, Tingting ; Fan, Qiming ; Qin, An ; Dai, Kerong</creator><creatorcontrib>Zhai, Zanjing ; Qu, Xinhua ; Li, Haowei ; Yang, Ke ; Wan, Peng ; Tan, Lili ; Ouyang, Zhengxiao ; Liu, Xuqiang ; Tian, Bo ; Xiao, Fei ; Wang, Wengang ; Jiang, Chuan ; Tang, Tingting ; Fan, Qiming ; Qin, An ; Dai, Kerong</creatorcontrib><description>Abstract Wear particle-induced aseptic prosthetic loosening is one of the most common reasons for total joint arthroplasty (TJA). Extensive bone destruction (osteolysis) by osteoclasts plays an important role in wear particle-induced peri-implant loosening. Thus, strategies for inhibiting osteoclast function may have therapeutic benefit for prosthetic loosening. Here, we mimicked the process of magnesium (Mg) degradation in vivo and obtained Mg leach liquor (MLL) by immersing pure Mg in culture medium. For the first time, we demonstrated that MLL suppresses osteoclast formation, polarization, and osteoclast bone resorption in vitro . An in vivo assay demonstrated that MLL attenuates wear particle-induced osteolysis. Furthermore, we found that MLL significantly inhibits nuclear factor-κB (NF-κB) activation by retarding inhibitor-κB degradation and subsequent NF-κB nuclear translocation. We also found that MLL attenuates the expression of NFATc1 at both the protein and mRNA levels. These results demonstrate that MLL has anti-osteoclast activity in vitro and prevents wear particle-induced osteolysis in vivo . Collectively, our study suggests that metallic magnesium, one of the orthopedic implants with superior properties, has significant potential for the treatment of osteolysis-related diseases caused by excessive osteoclast formation and function.</description><identifier>ISSN: 0142-9612</identifier><identifier>EISSN: 1878-5905</identifier><identifier>DOI: 10.1016/j.biomaterials.2014.04.044</identifier><identifier>PMID: 24816285</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Actins - metabolism ; Advanced Basic Science ; Animals ; Cell Death - drug effects ; Cell Line ; Cytokines - biosynthesis ; Dentistry ; Gene Expression Regulation - drug effects ; Hydrogen-Ion Concentration - drug effects ; Magnesium ; Magnesium - pharmacology ; Mice, Inbred C57BL ; Models, Biological ; NF-kappa B - metabolism ; NF-κB ; NFATC Transcription Factors - metabolism ; NFATc1 ; Osteoclast ; Osteoclasts - drug effects ; Osteoclasts - metabolism ; Osteoclasts - pathology ; Osteogenesis - drug effects ; Osteogenesis - genetics ; Osteolysis ; Osteolysis - pathology ; RANK Ligand - pharmacology ; Signal Transduction - drug effects ; Signal Transduction - genetics ; Skull - drug effects ; Skull - pathology ; Time Factors</subject><ispartof>Biomaterials, 2014-08, Vol.35 (24), p.6299-6310</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-26b7ba49b95de06512d5a9af2a1cb14626aefae97383b758be867f8de254e6b43</citedby><cites>FETCH-LOGICAL-c435t-26b7ba49b95de06512d5a9af2a1cb14626aefae97383b758be867f8de254e6b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24816285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhai, Zanjing</creatorcontrib><creatorcontrib>Qu, Xinhua</creatorcontrib><creatorcontrib>Li, Haowei</creatorcontrib><creatorcontrib>Yang, Ke</creatorcontrib><creatorcontrib>Wan, Peng</creatorcontrib><creatorcontrib>Tan, Lili</creatorcontrib><creatorcontrib>Ouyang, Zhengxiao</creatorcontrib><creatorcontrib>Liu, Xuqiang</creatorcontrib><creatorcontrib>Tian, Bo</creatorcontrib><creatorcontrib>Xiao, Fei</creatorcontrib><creatorcontrib>Wang, Wengang</creatorcontrib><creatorcontrib>Jiang, Chuan</creatorcontrib><creatorcontrib>Tang, Tingting</creatorcontrib><creatorcontrib>Fan, Qiming</creatorcontrib><creatorcontrib>Qin, An</creatorcontrib><creatorcontrib>Dai, Kerong</creatorcontrib><title>The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling</title><title>Biomaterials</title><addtitle>Biomaterials</addtitle><description>Abstract Wear particle-induced aseptic prosthetic loosening is one of the most common reasons for total joint arthroplasty (TJA). Extensive bone destruction (osteolysis) by osteoclasts plays an important role in wear particle-induced peri-implant loosening. Thus, strategies for inhibiting osteoclast function may have therapeutic benefit for prosthetic loosening. Here, we mimicked the process of magnesium (Mg) degradation in vivo and obtained Mg leach liquor (MLL) by immersing pure Mg in culture medium. For the first time, we demonstrated that MLL suppresses osteoclast formation, polarization, and osteoclast bone resorption in vitro . An in vivo assay demonstrated that MLL attenuates wear particle-induced osteolysis. Furthermore, we found that MLL significantly inhibits nuclear factor-κB (NF-κB) activation by retarding inhibitor-κB degradation and subsequent NF-κB nuclear translocation. We also found that MLL attenuates the expression of NFATc1 at both the protein and mRNA levels. These results demonstrate that MLL has anti-osteoclast activity in vitro and prevents wear particle-induced osteolysis in vivo . Collectively, our study suggests that metallic magnesium, one of the orthopedic implants with superior properties, has significant potential for the treatment of osteolysis-related diseases caused by excessive osteoclast formation and function.</description><subject>Actins - metabolism</subject><subject>Advanced Basic Science</subject><subject>Animals</subject><subject>Cell Death - drug effects</subject><subject>Cell Line</subject><subject>Cytokines - biosynthesis</subject><subject>Dentistry</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Hydrogen-Ion Concentration - drug effects</subject><subject>Magnesium</subject><subject>Magnesium - pharmacology</subject><subject>Mice, Inbred C57BL</subject><subject>Models, Biological</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB</subject><subject>NFATC Transcription Factors - metabolism</subject><subject>NFATc1</subject><subject>Osteoclast</subject><subject>Osteoclasts - drug effects</subject><subject>Osteoclasts - metabolism</subject><subject>Osteoclasts - pathology</subject><subject>Osteogenesis - drug effects</subject><subject>Osteogenesis - genetics</subject><subject>Osteolysis</subject><subject>Osteolysis - pathology</subject><subject>RANK Ligand - pharmacology</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - genetics</subject><subject>Skull - drug effects</subject><subject>Skull - pathology</subject><subject>Time Factors</subject><issn>0142-9612</issn><issn>1878-5905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNUsGO1DAMjRCIHRZ-AUWcuHRI0iRtOSAtCwNIq-XAcI7SxB0ytMmSpEjzAfwUH8E3kdIFIU5IlhLb79mynxF6QsmWEiqfHbe9C5POEJ0e05YRyrdkMX4HbWjbtJXoiLiLNiXBqk5SdoYepHQkxSec3UdnjLdUslZs0Lf9J8AwDGAyDgOeIOtxdAZP-uAhuXnCFg5RW51d8PgmBjubnHD5h5QhmFGnXDlfomDX0HhKLmHtLdY5g59XZql9vat-fH_5K3O9u9gbipM7eD06f3iI7g1lFHh0-56jj7vX-8u31dX7N-8uL64qw2uRKyb7pte86zthgUhBmRW60wPT1PSUSyY1DBq6pm7rvhFtD61shtYCExxkz-tz9HStWwb5MkPKanLJwDhqD2FOigrWtZzVpCnQ5yvUxJBShEHdRDfpeFKUqEUGdVR_y6AWGRRZbOnz-LbP3E9g_1B_770AXq0AKNN-dRBVMg58WaKLRQplg_u_Pi_-KWPKOp3R42c4QTqGOfqFQ1ViiqgPy0Es91DuoNCZrH8CDde33w</recordid><startdate>20140801</startdate><enddate>20140801</enddate><creator>Zhai, Zanjing</creator><creator>Qu, Xinhua</creator><creator>Li, Haowei</creator><creator>Yang, Ke</creator><creator>Wan, Peng</creator><creator>Tan, Lili</creator><creator>Ouyang, Zhengxiao</creator><creator>Liu, Xuqiang</creator><creator>Tian, Bo</creator><creator>Xiao, Fei</creator><creator>Wang, Wengang</creator><creator>Jiang, Chuan</creator><creator>Tang, Tingting</creator><creator>Fan, Qiming</creator><creator>Qin, An</creator><creator>Dai, Kerong</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140801</creationdate><title>The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling</title><author>Zhai, Zanjing ; Qu, Xinhua ; Li, Haowei ; Yang, Ke ; Wan, Peng ; Tan, Lili ; Ouyang, Zhengxiao ; Liu, Xuqiang ; Tian, Bo ; Xiao, Fei ; Wang, Wengang ; Jiang, Chuan ; Tang, Tingting ; Fan, Qiming ; Qin, An ; Dai, Kerong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-26b7ba49b95de06512d5a9af2a1cb14626aefae97383b758be867f8de254e6b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Actins - metabolism</topic><topic>Advanced Basic Science</topic><topic>Animals</topic><topic>Cell Death - drug effects</topic><topic>Cell Line</topic><topic>Cytokines - biosynthesis</topic><topic>Dentistry</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Hydrogen-Ion Concentration - drug effects</topic><topic>Magnesium</topic><topic>Magnesium - pharmacology</topic><topic>Mice, Inbred C57BL</topic><topic>Models, Biological</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB</topic><topic>NFATC Transcription Factors - metabolism</topic><topic>NFATc1</topic><topic>Osteoclast</topic><topic>Osteoclasts - drug effects</topic><topic>Osteoclasts - metabolism</topic><topic>Osteoclasts - pathology</topic><topic>Osteogenesis - drug effects</topic><topic>Osteogenesis - genetics</topic><topic>Osteolysis</topic><topic>Osteolysis - pathology</topic><topic>RANK Ligand - pharmacology</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - genetics</topic><topic>Skull - drug effects</topic><topic>Skull - pathology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhai, Zanjing</creatorcontrib><creatorcontrib>Qu, Xinhua</creatorcontrib><creatorcontrib>Li, Haowei</creatorcontrib><creatorcontrib>Yang, Ke</creatorcontrib><creatorcontrib>Wan, Peng</creatorcontrib><creatorcontrib>Tan, Lili</creatorcontrib><creatorcontrib>Ouyang, Zhengxiao</creatorcontrib><creatorcontrib>Liu, Xuqiang</creatorcontrib><creatorcontrib>Tian, Bo</creatorcontrib><creatorcontrib>Xiao, Fei</creatorcontrib><creatorcontrib>Wang, Wengang</creatorcontrib><creatorcontrib>Jiang, Chuan</creatorcontrib><creatorcontrib>Tang, Tingting</creatorcontrib><creatorcontrib>Fan, Qiming</creatorcontrib><creatorcontrib>Qin, An</creatorcontrib><creatorcontrib>Dai, Kerong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomaterials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhai, Zanjing</au><au>Qu, Xinhua</au><au>Li, Haowei</au><au>Yang, Ke</au><au>Wan, Peng</au><au>Tan, Lili</au><au>Ouyang, Zhengxiao</au><au>Liu, Xuqiang</au><au>Tian, Bo</au><au>Xiao, Fei</au><au>Wang, Wengang</au><au>Jiang, Chuan</au><au>Tang, Tingting</au><au>Fan, Qiming</au><au>Qin, An</au><au>Dai, Kerong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling</atitle><jtitle>Biomaterials</jtitle><addtitle>Biomaterials</addtitle><date>2014-08-01</date><risdate>2014</risdate><volume>35</volume><issue>24</issue><spage>6299</spage><epage>6310</epage><pages>6299-6310</pages><issn>0142-9612</issn><eissn>1878-5905</eissn><abstract>Abstract Wear particle-induced aseptic prosthetic loosening is one of the most common reasons for total joint arthroplasty (TJA). Extensive bone destruction (osteolysis) by osteoclasts plays an important role in wear particle-induced peri-implant loosening. Thus, strategies for inhibiting osteoclast function may have therapeutic benefit for prosthetic loosening. Here, we mimicked the process of magnesium (Mg) degradation in vivo and obtained Mg leach liquor (MLL) by immersing pure Mg in culture medium. For the first time, we demonstrated that MLL suppresses osteoclast formation, polarization, and osteoclast bone resorption in vitro . An in vivo assay demonstrated that MLL attenuates wear particle-induced osteolysis. Furthermore, we found that MLL significantly inhibits nuclear factor-κB (NF-κB) activation by retarding inhibitor-κB degradation and subsequent NF-κB nuclear translocation. We also found that MLL attenuates the expression of NFATc1 at both the protein and mRNA levels. These results demonstrate that MLL has anti-osteoclast activity in vitro and prevents wear particle-induced osteolysis in vivo . Collectively, our study suggests that metallic magnesium, one of the orthopedic implants with superior properties, has significant potential for the treatment of osteolysis-related diseases caused by excessive osteoclast formation and function.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>24816285</pmid><doi>10.1016/j.biomaterials.2014.04.044</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0142-9612
ispartof Biomaterials, 2014-08, Vol.35 (24), p.6299-6310
issn 0142-9612
1878-5905
language eng
recordid cdi_proquest_miscellaneous_1529842307
source Elsevier
subjects Actins - metabolism
Advanced Basic Science
Animals
Cell Death - drug effects
Cell Line
Cytokines - biosynthesis
Dentistry
Gene Expression Regulation - drug effects
Hydrogen-Ion Concentration - drug effects
Magnesium
Magnesium - pharmacology
Mice, Inbred C57BL
Models, Biological
NF-kappa B - metabolism
NF-κB
NFATC Transcription Factors - metabolism
NFATc1
Osteoclast
Osteoclasts - drug effects
Osteoclasts - metabolism
Osteoclasts - pathology
Osteogenesis - drug effects
Osteogenesis - genetics
Osteolysis
Osteolysis - pathology
RANK Ligand - pharmacology
Signal Transduction - drug effects
Signal Transduction - genetics
Skull - drug effects
Skull - pathology
Time Factors
title The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A35%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20metallic%20magnesium%20degradation%20products%20on%20osteoclast-induced%20osteolysis%20and%20attenuation%20of%20NF-%CE%BAB%20and%20NFATc1%20signaling&rft.jtitle=Biomaterials&rft.au=Zhai,%20Zanjing&rft.date=2014-08-01&rft.volume=35&rft.issue=24&rft.spage=6299&rft.epage=6310&rft.pages=6299-6310&rft.issn=0142-9612&rft.eissn=1878-5905&rft_id=info:doi/10.1016/j.biomaterials.2014.04.044&rft_dat=%3Cproquest_cross%3E1529842307%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-26b7ba49b95de06512d5a9af2a1cb14626aefae97383b758be867f8de254e6b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1529842307&rft_id=info:pmid/24816285&rfr_iscdi=true